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Background. Several studies have examined determinants related to post-stroke fatigue. However, it is unclear which determinants
can predict an increase in poststroke fatigue over time. Aim. This prospective cohort study aimed to identify determinants which
predict an increase in post-stroke fatigue. Methods. A total of 250 patients with stroke were examined at inpatient rehabilitation
discharge (T0) and 24 weeks later (T1). Fatigue was measured using the Fatigue Severity Scale (FSS). An increase in post-stroke
fatigue was defined as an increase in the FSS score beyond the 95% limits of the standard error of measurement of the FSS (i.e.,
1.41 points) between T0 and T1. Candidate determinants included personal factors, stroke characteristics, physical, cognitive, and
emotional functions, and activities and participation and were assessed at T0. Factors predicting an increase in fatigue were
identified using forward multivariate logistic regression analysis. Results. The only independent predictor of an increase in post-
stroke fatigue was FSS (OR 0.50; 0.38–0.64, P < 0.001). The model including FSS at baseline correctly predicted 7.9% of the
patients who showed increased fatigue at T1. Conclusion. The prognostic model to predict an increase in fatigue after stroke has
limited predictive value, but baseline fatigue is the most important independent predictor. Overall, fatigue levels remained stable
over time.
1. Introduction
A common symptom after stroke is fatigue, with reported
frequencies ranging from 38% to 77% [1], indicating that
poststroke fatigue is a major problem after stroke. Forty per-
cent of the patients considered fatigue to be one of the worst
sequelae of stroke [2]. Patients feel unprepared for the fatigue
phenomenon and struggle to adapt to it in daily life [3]. Fati-
gue has a debilitating influence on activities of daily living
[3, 4] and is independently associated with health-related
quality of life [4] and the resumption of paid work [5].
Several studies have examined determinants related to
poststroke fatigue, but for many determinants there is incon-
clusive or insuﬃcient evidence [1]. A recent prospective
study demonstrated that baseline fatigue was the main pre-
dictor of the development of poststroke fatigue over time
[6]. Conflicting evidence was found for personal factors
such as gender [2, 7–12], age [2, 6–12], and marital status
[7, 8]. A few studies found significant results for stroke chara-
cteristics, for example, previous stroke [7] and infratentorial
infarctions [6, 11]. A strong relationship between depression
and post-stroke fatigue was described, both in cross-
sectional [2, 10, 11] and longitudinal analyses [6–9]. How-
ever, poststroke fatigue can also occur in the absence of de-
pression, and depression was also found independent of
fatigue in stroke survivors [2, 10]. A multivariate model in-
cluding age, sex, locus of control, and depression explained
20% of the total variance of FSS scores 1 year after stroke [8].
This meant that the largest part of the variance in post-
stroke fatigue, 80%, remained unexplained, suggesting that
other determinants play a role in the occurrence of post-
stroke fatigue. One hypothesis is that physical decondition-
ing, which is common after stroke [13], might be associated
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with poststroke fatigue [14]. The influence of physical
functioning has not been extensively investigated, and results
have been inconsistent [15, 16].
Reported levels of poststroke fatigue are high and remain
fairly stable over time within groups. At an individual level,
however, significant changes do occur [6, 8]. It might in fact
be more relevant for clinical practice to identify those pa-
tients with a variable course of fatigue and especially the pa-
tients who are at risk for an increase in poststroke fatigue.
Therefore, the aim of the present prospective cohort study
was to identify determinants predicting increasing fatigue in
patients after stroke. Candidate determinants include per-
sonal factors, stroke characteristics, physical, cognitive, and
emotional functions, and activities and participation.
2. Methods
2.1. Design and Procedure. Data used in this study were col-
lected between July 2008 and January 2011 as part of a large
randomized controlled trial called FIT-Stroke (trial number
NTR1534). The primary objective of the FIT-Stroke trial was
to evaluate the eﬀects on gait and the cost-eﬀectiveness of
a structured, progressive task-oriented circuit class training
(CCT) program, compared to usual physical therapy care
during outpatient rehabilitation in a rehabilitation center
[17].
Patients were included in the study (T0) at the time of
discharge from inpatient rehabilitation, when outpatient
rehabilitation started. The followup assessment (T1) took
place 24 weeks after discharge.
All measures were assessed by an independent researcher.
2.2. Participants. Inclusion criteria to participate in the study
were (1) verified stroke according to the WHO definition
[18]; (2) age ≥18 years; (3) ability to walk a minimum of
10mwithout physical assistance from a therapist (Functional
Ambulation Categories≥3) [19]; (4) having been discharged
home from a rehabilitation center; (5) giving informed
consent. Patients were excluded if they (1) had a score on the
Mini-Mental State Examination of less than 24 points [20];
(2) were unable to communicate (i.e., <4 points on the
Utrechts Communicatie Onderzoek test) [21]; (3) livedmore
than 30 km from the rehabilitation center.
The study was approved by the Medical Ethics Com-
mittee of the University Medical Center Utrecht and all the
participating rehabilitation centers. All included patients
gave written informed consent.
2.3. Measures
2.3.1. Primary Outcome: Poststroke Fatigue. The impact of
fatigue was measured by the Fatigue Severity Scale (FSS)
[22]. The FSS consists of 9 items, with scores for each item
ranging from 1 to 7. The total FSS score is the mean of the 9
item scores [22]. Patients with a total score of ≥4 points
are classified as “fatigued” [23]. A reliability study with two
independent observers and 18 stroke patients found an
Intraclass Correlation Coeﬃcient (ICC) for the FSS of 0.82
[4]. Item analysis showed excellent internal consistency and
reliability for stroke patients (Cronbach’s α = 0.96) [23]. In
healthy subjects, the test-retest scores were stable over time
[23]. The FSS scale was administered at T0 and T1. An in-
crease in poststroke fatigue was defined as an increase in
the FSS score beyond the 95% limits of the standard error
of measurement (SEM) of the FSS, SEM being defined as
SEM = SD∗√1−ICC. The SD of the FSS was obtained from
the current study. The ICC of the FSS used in our analysis was
0.82 [4].
2.3.2. Candidate Determinants. Determinants were classified
using the International Classification of Functioning, disabil-
ity and health (ICF). All candidate determinants were assess-
ed at T0.
2.3.3. Personal Factors. Data on age, sex, marital status, phys-
ical activity, and comorbidity before stroke were obtained at
T0. A person was classified as “physically active before stroke”
if he or she participated in moderate-intensity activity for at
least 30 minutes a day, on five days a week [24]. Comorbidity
was assessed by the Cumulative Illness Rating Scale (CIRS),
which is a valid and reliable instrument that addresses all
relevant body systems without using specific diagnoses [25].
The CIRS consists of 13 items, and the total score ranges from
0 (i.e., no morbidity) to 52 (very severe comorbidities).
2.3.4. Stroke Characteristics. Data on type of stroke, lateral-
ization, time since stroke onset, and previous stroke were ob-
tained from medical records at T0. Type of stroke was clas-
sified as ischemic versus hemorrhagic stroke. Lateralization
was divided into three categories namely right hemisphere,
left hemisphere, and other (e.g., brainstem, cerebellum).
2.3.5. Physical Functions. Strength was assessed by theMotri-
city Index (MI), which was used to determine the strength of
the upper paretic limb (MI upper limb) and the lower par-
etic limb (MI lower limb). Scores range from 0 (no visual
movement) to 100 (normal strength). The test has proven to
be highly reliable and valid [26].
Strength was also assessed by the “strength” domain of
the Stroke Impact Scale, version 3.0 (SIS). The SIS is a self-
reported, stroke-specific measure that includes 59 items and
assesses 8 domains relating to activities and participation
[27]. SIS has shown excellent clinimetric properties in terms
of concurrent and construct validity, test-retest reliability
and responsiveness [28, 29]. The SIS has been translated into
Dutch, and the translated version also proved to be valid and
responsive [30]. Subscale scores range from 0 to 100 percent
[28].
Balance was tested by the Timed Balance Test (TBT). The
TBT consists of 5 components scored on an ordinal scale and
involves timed balance (i.e., 60 seconds) in five diﬀerent posi-
tions of bilateral stance. One point is scored for each position
maintained, so the score ranges from 0 to 5. The test has been
shown to be reliable and concurrent valid [31, 32].
2.3.6. Cognitive Functions. Cognition was assessed by the
MMSE, a widely used brief screening instrument to
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determine orientation, memory, attention, calculation, lan-
guage, and construction functions [20]. The score ranges
from 0 to 30. A subject who scored less than 24 on theMMSE
was considered to have cognitive impairments. Patients with
an MMS < 24 were excluded from the study.
Memory function was assessed by the “memory” domain
of the SIS, with subscale scores range from 0 to 100 [28].
Inattention was measured by the Letter Cancellation Task
and was regarded as positive when patients had two or more
omissions on one side compared to the other side [33].
2.3.7. Emotional Functions. The Hospital Anxiety and De-
pression Scale (HADS) was used to determine mood, emo-
tional distress, anxiety, depression, and emotional disorder. It
is a brief, valid, reliable, and widely used instrument, known
to produce meaningful results as a psychological screening
tool. TheHADS consists of 14 items (7 anxiety, 7 depression),
each with a 4-point rating scale (0–3) and is responsive to
change [34, 35]. The depression and anxiety scales are anal-
yzed as two separate domains, with scores for each scale rang-
ing from 0 to 21.
Emotion was assessed by the corresponding domain on
the SIS, with subscale scores range from 0 to 100 [28].
The Falls Eﬃcacy Scale (FES) was used to measure fear of
falling. The FES is based on the operational definition of this
fear as “low perceived self-eﬃcacy at avoiding falls during
essential, nonhazardous activities of daily living” [36]. The
score ranges from 0 to 130, with higher scores representing
higher confidence and thus less anxiety.
2.3.8. Activities and Participation. Gait performance and
endurance were assessed by the 6-Minute Walking Test
(6MWT), which has a good test-retest reliability (ICC =
0.973) [37–39].
The 5-Meter Timed Walking Test (5MTWT) was used to
assess comfortable walking speed [40]. To reduce measure-
ment error, we used the mean of three repeated walking
speed measurements.
The Functional Ambulation Categories (FAC) instru-
ment was used to assess walking ability. The scale includes
six categories with scores ranging from 0 to 5, that is, from
unable to walk to independently walking without physical
assistance [19, 41], though only patients with FAC 3 or higher
were included in the trial.
Mobility was assessed by the Rivermead Mobility Index
(RMI). The RMI consists of 14 questions and one obser-
vation (maximum score 15), covering aspects ranging from
turning in bed to running [42]. Questions are simple and
are scored dichotomously. The measure is reliable, valid, and
responsive [42–44].
Extended activities of daily living (ADL) performance
was assessed by the Nottingham Extended ADL (NEADL).
The NEADL scale [45] is based on a self-reported question-
naire on levels of activity actually performed. The NEADL
consists of 22 items in 4 domains (mobility, kitchen, dom-
estic, and leisure). It has proven to be reliable and valid as
an outcomemeasure in trials and observational studies. Each
item is rated by one of four responses (able, able with
diﬃculty, able with help, unable) and scores range from 0
to 66.
Activity and participation domains of the SIS, that is,
hand function, mobility, communication, ADL/IADL, and
participation were also included in the analysis, with subscale
scores ranging from 0 to 100 [28].
2.4. Statistics. Baseline characteristics were described using
descriptive statistics (means and Standard Deviations (SDs);
medians and ranges, odds ratio (95% confidence interval)).
First, bivariate logistic regression analyses were conduct-
ed with the candidate determinants measured at T0. Candi-
date determinants with a significance level of P < 0.2 were
then selected for the forward multivariate logistic regression
to identify independent predictors of an increase in fatigue
at T1 (i.e., fatigue scores increasing beyond the 95% limits of
the SEM).Multicollinearity was checked bymeans of Pearson
correlation, with a correlation coeﬃcient of r > 0.7 being
classified as multicollinearity. If the correlation coeﬃcient
was >0.7, the variable with the lowest coeﬃcient, relative
to the outcome measure was omitted. Goodness of fit of
the multivariate logistic model was tested by the Hosmer
Lemeshow test. A significance level of 0.05 was used to
include a determinant in the model. We used a generally ac-
cepted rule of thumb for the maximum number of factors in
a regression analysis, viz. one determinant was added to the
equation for every 10 patients [46]. The present cohort parti-
cipated in an intervention trial on the cost-eﬀectiveness of
circuit class training after stroke [17]. Preliminary results
show that there are no time and interaction eﬀects of treat-
ment allocation with fatigue. The complete cohort was there-
fore included in the present analysis. Data were analyzed
using SPSS for Windows version 16.0.
3. Results
3.1. Baseline Characteristics. Two hundred and fifty patients
were included in the study, and 243 patients were still eligible
at T1. Two patients died, two were excluded due to recurrent
stroke, and three patients withdrew from the study. FSS
scores at T1 were missing for one patient, so 242 patients
were included in this analysis.
Themean age of the group as a whole (N = 242) was 57.1
years (SD = 10.3 years); 64.9% of the patients were male. The
average length of inpatient stay at the rehabilitation center
was 72.1 days (SD 37.5). At the time of inclusion, the mean
time since stroke onset was 97.0 days (SD 46.9).
3.2. Poststroke Fatigue. Fatigue was reported by 58.3% and
55.0% of the patients at T0 and T1, respectively. Mean FSS
score was 4.1 (SD 1.7) at both measurements (P = 0.83). In
40.5% (N = 98) of the patients, fatigue (FSS≥ 4) was present
at both measurements, while about a quarter (N = 66) of
the patients reported no fatigue at either measurement. Over
50% of the patients reported that fatigue was one of the three
most disabling symptoms after stroke (score ≥5 on item 8 of
the FSS).
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FSS: Fatigue Severity Scale, SD: Standard Deviation.
The 95% SEM of the FSS was (1.7∗√(1−0.82))∗1.96 =
1.41. A patient was classified as “having increased fatigue”
when the score at T1 was 1.41 points higher than that at T0.
Using the 95% limits of the SEM, 38 patients (15.7%)
showed an increased fatigue score, while FSS scores had
decreased in 43 patients (17.8%), and the majority of the
patients had remained stable in this respect (66.5%). Table 1
shows FSS scores for each group at both baseline and fol-
lowup.
3.3. Regression Analysis. Logistic regression analysis was con-
ducted, comparing the group showing an increase in fatigue
with the reference group (i.e., those with stable or decreased
FSS scores). Baseline characteristics of both groups are re-
ported in Table 2. Bivariate analysis of the determinants
measured at T0 showed six determinants with P < 0.2,
viz. time since stroke, MI upper limb, 6MWT, MMSE, SIS
memory, and FSS score at T0 (Table 2). Since there was no
multicollinearity between these six determinants, all deter-
minants were included in the multivariate logistic regression
analysis. The only independent predictor of an increase in
poststroke fatigue was the FSS score at T0 (OR 0.50 [0.38-
0.64], Nagelkerke R2 = 0.243). The multivariate model
showed a good fit (Hosmer and Lemeshow test P = 0.495).
Themodel including FSS at baseline correctly predicted 7.9%
(3 of 38) of the patients whose fatigue had increased at T1
and 96.6% (197 of 204) of the reference group.
4. Discussion
In our study, the FSS score measured at T0 was the only
independent predictor of an increase in fatigue over time.
Nevertheless, a model including the FSS score at T0 still
poorly predicted an increase in poststroke fatigue. Our find-
ings also indicate that poststroke fatigue is experienced by
the majority of stroke patients, with 58.3 and 55.0% of our
patients reporting fatigue at T0 and T1, respectively. A large
proportion (40.5%) of our patients were fatigued at both
measurements, and 66.5% of the patients remained within
the 95% limits of the SEM of the FSS, suggesting that the
initial scores on the FSS are highly indicative for FSS scores
at followup. This result further confirms that poststroke
fatigue is a major problem after stroke, even in a relatively
young and moderately aﬀected population like ours, which
remained fairly stable over time. However, the followup of
the present study was restricted to 24 weeks. With that, it
remains unclear if a longer followup would have resulted in
the same conclusion.
A strong point of the current study was the large sample
size of 250 participants and the use of a large variety of poten-
tial predictors at the diﬀerent levels of the ICF. Some limi-
tations need to be taken into account, however, when inter-
preting the results.
First, despite the large number of determinants included
in the study, the multivariate regression model was a poor
predictor of an increase in poststroke fatigue. This is in line
with previously published studies [8, 12, 15, 16, 47]. In con-
trast to most other studies [2, 10, 11, 47, 48], our study ex-
amined the physical determinants by means of physical per-
formance tests instead of using nonperformance measures
like the Oxford Handicap Scale, modified Rankin Scale, SF-
36, or Glasgow Outcome Scale. Our bivariate analysis sug-
gested that the strength of the upper limb (MI) and the dis-
tance on the 6MWT were significantly related (P < 0.2) to
an increase in fatigue over time. However, neither variable
was included in the final multivariate model, suggesting that
these physical determinants were not independent predictors
of an increased fatigue score at T1.
The present study did not take determinants at the level
of cognitive function and coping style suﬃciently into ac-
count, which may have influenced the results. Previous stud-
ies found significant relations between poststroke fatigue and
factors like cognition [48] and coping style [8, 48]. In our
study, two of the three examined cognitive measures were
included in the multivariate analysis, but they did not prove
to be significantly related to an increase in poststroke fatigue.
Although objective measures are generally preferred for cog-
nition, we used a self-reported questionnaire and two global
screening instruments, which may have influenced the re-
sults. Also, since we used theMMSE as an inclusion criterion,
cognitive limitations in our sample were moderate.
Second, since there is no generally accepted definition of
fatigue, there is no golden standard to measure poststroke
fatigue either. Our study used the FSS to measure fatigue.
Although this is a widely accepted and used scale to measure
fatigue in stroke populations [1], this choice may have influe-
nced the results.
Third, the use of an inception cohort at a fixed time
after stroke onset is preferred in prognostic research, whereas
our study took the baseline measurement at the time of dis-
charge from inpatient rehabilitation, and there was a mean
time interval between measurements of 96.9 days with a
standard deviation of 46.9 days. Despite this, the frequency of
poststroke fatigue found in our study is comparable to that
reported in other studies using a similar timeframe [1, 8].
Also, time since stroke onset turned out not to be an indep-
endent predictor of an increase in poststroke fatigue.
To our knowledge, this is the first study which specifically
attempted to identify patients whose poststroke fatigue in-
creased over time. The significant odds ratio of 0.5 found
in our study suggests that patients with higher baseline FSS
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Table 2: Baseline characteristics and bivariate logistic regression analysis related to increased fatigue.




N = 204 OR (95% CI) P value
Personal factors
Age, mean ± SD 56.9± 10.4 57.1± 10.3 1.00 (0.97–1.03) 0.915
Male 63.2% 65.2% 1.10 (0.53–2.24) 0.809
Physically active before Stroke (yes) 81.6% 78.9% 1.88 (0.63–5.63) 0.261
CIRS, mean ± SD 6.1± 3.7 5.5± 2.6 1.07 (0.95–1.21) 0.251
Marital status; living with partner 78.9% 82.8% 0.78 (0.33–1.84) 0.565
Stroke characteristics





Left hemisphere 1.38 (0.65–2.94) 0.404
Other 1.05 (0.38–2.90) 0.925
Time since stroke (days) 108.8± 53.9 94.8± 94.8 1.06 (0.999–1.01) 0.094∗
Previous stroke (yes) 10.5% 10.8% 0.812 (0.43–1.51) 0.513
Physical functions
MI upper limb, mean ± SD 55.1± 29.3 61.3± 25.8 0.99 (0.98–1.00) 0.185∗
MI lower limb, mean ± SD 67.4± 21.4 68.1± 20.1 1.00 (0.98–1.02) 0.843
SIS-strength, mean ± SD 53.6± 21.3 51.5± 19.9 1.01 (0.99–1.02) 0.546
TBT, median (range) 3.5 (1–5) 3 (0–5) 0.89 (0.65–1.23) 0.491
Cognitive functions
MMSE, mean ± SD 28.5± 1.6 28.0± 1.7 1.21 (0.96–1.51) 0.104∗
SIS-memory, mean ± SD 85.3± 13.9 81.4± 17.8 1.02 (0.99–1.04) 0.194∗
Inattention (yes) 13.2% 21.6% 0.55 (0.20–1.50) 0.242
Psychological characteristics
HADS-depression, mean ± SD 4.6± 3.6 4.8± 3.4 0.98 (0.88–1.09) 0.706
HADS-anxiety, mean ± SD 3.3± 2.8 3.8± 3.5 0.95 (0.85–1.06) 0.338
SIS-emotion, mean ± SD 80.6± 13.4 82.8± 13.7 1.00 (0.97–1.01) 0.353
FES, mean ± SD 97.1± 21.0 97.3± 19.2 1.00 (0.98–1.02) 0.955
FSS, mean ± SD 2.7± 1.3 4.4± 1.6 0.50 (0.38–0.64) 0.000∗
Activities and participation
6MWT, mean distance ± SD 279.1± 132.1 326.6± 126.0 1.00 (0.99-1.00) 0.037∗
5MTWT, mean time ± SD 9.0± 6.1 8.1± 7.9 1.01 (0.97–1.05) 0.521
FAC, median (range) 5 (4-5) 5 (3–5) 0.78 (0.45–1.34) 0.361
RMI, mean ± SD 12.4± 1.5 12.5± 1.9 0.99 (0.82–1.20) 0.930
NEADL, mean ± SD 32.3± 10.5 34.0± 11.1 0.99 (0.96–1.02) 0.372
SIS-mobility, mean ± SD 79.0± 14.9 79.2± 14.2 1.00 (0.98–1.02) 0.940
SIS-hand function, mean ± SD 41.4± 38.7 45.5± 34.8 1.00 (0.99–1.01) 0.520
SIS-ADL/IADL, mean ± SD 67.1± 16.0 70.4± 15.2 0.99 (0.97–1.01) 0.238
SIS-communication, mean ± SD 83.4± 22.8 85.2± 18.2 1.00 (0.79–1.01) 0.579
SIS-participation, mean ± SD 63.4± 24.3 67.0± 20.3 0.99 (0.98–1.01) 0.329
∗
Reference group: those with stable or decreased FSS scores; CIRS: Cumulative Illness Rating Scale, MI: Motricity Index, SIS: Stroke Impact Scale, TBT:
Timed Balance Test, MMSE: Mini-Mental State Examination, HADS: Hospital Anxiety Depression Scale, FES: Falls Eﬃcacy Scale, FSS: Fatigue Severity Scale,
6MWT: 6-Minute Walking Test, 5MTWT: 5-Meter Timed Walking Test, FAC: Functional Ambulation Categories, RMI: Rivermead Mobility Index, NEADL:
Nottingham extended activities of daily living, CI: Confidence Interval ∗P value <0.2, included in the multivariate logistic regression analysis.
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scores are less likely to show increased fatigue (i.e., having a
higher FSS score) in the long term. This is in contrast to the
findings by Snaphaan et al. who reported that a higher fatigue
score at baseline was related to a change from no fatigue
at baseline to the presence of fatigue at followup (incident
fatigue) [6]. Although the biological explanation for our
finding remains unclear, the decreased likelihood to show an
increase in FSS beyond the 95% limits of the SEM may be
caused by a ceiling eﬀect of the FSS and hence regression to
the mean. Patients with high initial scores on a scale are more
likely to show declining scores, whereas patients with very
low scores at baseline are more likely to show an increase at a
second assessment.
A significant relation between poststroke fatigue and de-
pression has been shown in several studies [2, 7, 8, 10]. The
study by Snaphaan et al. suggested that patients with fatigue
at followup but not at baseline had higher baseline scores
for depression compared to patients with no fatigue at either
of these times [6]. The strong relation between fatigue and
depression is consistent with the fact that fatigue is a sym-
ptom of depression. However, it has been shown that fatigue
can occur without the presence of depression [8]. In our
study, no significant relationship was found between depres-
sion and an increase in poststroke fatigue over time.
An ability to identify risk factors for an increase in post-
stroke fatigue will benefit eﬀorts to design treatment modal-
ities and counsel patients and their relatives. Currently, there
is insuﬃcient evidence to decide which treatment, whether
pharmaceutical or by (multidisciplinary) rehabilitation,
would be preferable [49]. Further research, for example, well-
designed randomized controlled trials, will be necessary to
show which interventions can be eﬀective. Recently publish-
ed preliminary results of a randomized controlled trial on
the eﬀect of combined graded physical activity training and
cognitive treatment to treat poststroke fatigue show a sig-
nificant decline in fatigue severity immediately after the
treatment as well as 6 months after treatment [50]. Since
coping style is an important factor in poststroke fatigue
[8, 48], this is an important aspect to consider for inclusion
in treatment. In addition to further exploration of eﬀective
treatment modalities, further research is needed to examine
the determinants related to poststroke fatigue. The role of
physical functioning should be further explored, since this
has hardly been included in prognostic research so far. Post-
stroke fatigue is a multifactorial phenomenon which is pro-
bably not captured by one single outcome measurement.
Therefore, future studies should consider including determi-
nants of diﬀerent domains and using various outcome meas-
urements to determine the diﬀerent dimensions of fatigue.
5. Conclusion
Baseline fatigue is the only independent predictor of an in-
crease in poststroke fatigue, and predicting poststroke fatigue
remains diﬃcult. Most patients remain stable over time,
meaning that the initial FSS scores are indicative of followup
scores. A high percentage of our relatively young and mod-
erately aﬀected sample suﬀered from poststroke fatigue,
indicating that this is a major problem in this group of stroke
survivors.
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